Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print March 18, 2009, doi:10.1212/01.wnl.0b013e3181a2a4ea)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
01.wnl.0b013e3181a2a4eav1
73/4/258    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Greving, J. P.
Right arrow Articles by Algra, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greving, J. P.
Right arrow Articles by Algra, A.
Related Collections
Right arrow Cost effectiveness/economic
Right arrow Decision analysis
Right arrow Harm/ risk (analysis)
Right arrow Subarachnoid hemorrhage
Right arrowRelated Article
NEUROLOGY 2009;73:258-265
© 2009 American Academy of Neurology

Cost-effectiveness of preventive treatment of intracranial aneurysms

New data and uncertainties

Jacoba P. Greving, PhD, Gabriël J.E. Rinkel, MD, Erik Buskens, MD and Ale Algra, MD

From the Julius Center for Health Sciences and Primary Care (J.P.G., A.A.) and Department of Neurology and Neurosurgery, Rudolf Magnus Institute of Neuroscience (G.J.E.R., A.A.), University Medical Center Utrecht; and Department of Epidemiology (E.B.), University Medical Center Groningen, University of Groningen, The Netherlands.

Address correspondence and reprint requests to Dr. Jacoba P. Greving, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Stratenum 6.131, PO Box 85500, 3508 GA Utrecht, The Netherlands J.P.Greving{at}umcutrecht.nl

Background: Previous modeling studies on treatment of unruptured intracranial aneurysms largely disregarded detailed data on treatment risks and omitted several factors that could influence cost-effectiveness. We performed a cost-effectiveness analysis of surgical and endovascular treatment of unruptured aneurysms for different rupture rates and life expectancies, and assessed the influence of excess mortality risks in these persons, de novo development of aneurysms, and utility of awareness of having an untreated aneurysm, and also identified important factors for which data are lacking.

Methods: We used a Markov model to compare surgical, endovascular, and no treatment of unruptured intracranial aneurysms. Inputs for the model were taken mainly from meta-analyses. Direct medical costs were derived from Dutch cost studies and expressed in 2005 Euros. We performed sensitivity analyses to evaluate model robustness.

Results: For 50-year-old patients, treatment of unruptured aneurysms is cost-effective for all rupture rate scenarios between 0.3% and 3.5%/year. In 70-year-old patients, treatment is not cost-effective in men with rupture rates ≤1%/year and women with rupture rates ≤0.5%/year. With lower utility of awareness of an untreated aneurysm, the cost-effectiveness of treatment strongly increased. The effect of excess mortality risks on the incremental cost-effectiveness ratios was modest. The risk of formation of new aneurysms had no relevant impact.

Conclusions: Patients' life expectancy, risk of rupture, and utility of awareness of an untreated aneurysm mainly define cost-effectiveness. However, important uncertainties remain on the rupture risk according to size and location of the aneurysm and on the utility of awareness of untreated aneurysm. More data on these factors are needed to define and individualize cost-effectiveness analyses.

Abbreviations: ICER = incremental cost-effectiveness ratios; ISUIA = International Study of Unruptured Intracranial Aneurysms; QALY = quality-adjusted life-year; SAH = subarachnoid hemorrhage.


Received June 10, 2008. Accepted in final form November 21, 2008.

Supplemental data at www.neurology.org

Editorial, page 254

e-Pub ahead of print on March 18, 2009, at www.neurology.org.

Disclosure: The authors report no disclosures.


Related Article

Choosing a treatment for unruptured aneurysms
James C. Torner, Nicholas C. Bambakidis, Robert W. Tarr, and Warren R. Selman
Neurology 2009 73: 254-255. [Full Text] [PDF]



This article has been cited by other articles:


Home page
JWatch NeurologyHome page
Preventative Treatment of Intracranial Aneurysms
Journal Watch Neurology, November 3, 2009; 2009(1103): 1 - 1.
[Full Text]


Home page
NeurologyHome page
J. C. Torner, N. C. Bambakidis, R. W. Tarr, and W. R. Selman
Choosing a treatment for unruptured aneurysms
Neurology, July 28, 2009; 73(4): 254 - 255.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by AAN Enterprises, Inc.